The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.
Modules, networks and systems medicine for understanding disease and aiding diagnosis
Open accessAbstract
Many common diseases, such as asthma, diabetes or obesity, involve altered interactions between thousands of genes. High-throughput techniques (omics) allow identification of such genes and their products, but functional understanding is a formidable challenge. Network-based analyses of omics data have identified modules of disease-associated genes that have been used to obtain both a systems level and a molecular understanding of disease mechanisms. For example, in allergy a module was used to find a novel candidate gene that was validated by functional and clinical studies. Such analyses play important roles in systems medicine. This is an emerging discipline that aims to gain a translational understanding of the complex mechanisms underlying common diseases. In this review, we will explain and provide examples of how network-based analyses of omics data, in combination with functional and clinical studies, are aiding our understanding of disease, as well as helping to prioritize diagnostic markers or therapeutic candidate genes. Such analyses involve significant problems and limitations, which will be discussed. We also highlight the steps needed for clinical implementation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 A disease module. (a) Conceptual model of how disease-associated genes (blue nodes), identified by high-throughput analysis, tend to co-localize in the human protein-protein interaction network (white nodes), forming a module (blue oval). The genes in the module are assumed to be more important for the disease than extramodular genes. (b) An actual disease module from allergic patients, showing extracellular proteins that were putatively co-regulated with IL13. Blue nodes are associated with cytokine activity, purple nodes are associated with hormone activity, and orange nodes are associated with growth factor activity according to Gene Ontology Molecular Function. The diagram in (b) is reproduced, with permission, from Bruhn et al. Science Translational Medicine 2014 [33].](https://figures.cochat.ai/paper-figures/4abe5db5dfad4c40aaa01e5e99c6cbc4/modules-networks-and-systems-medicine-for-understanding-disease-and-aiding-figure-2.jpg)


![Figure 5 Relationship between different disease modules on the protein-protein interaction network. (a) A hypothetical model of three different diseases mapped on the human protein-protein interaction network. The modules are dispersed in the network. (b) Instead, meta-analysis of mRNA microarray and genome-wide association study data show that disease modules partially overlap and form a shared module (grey) [39]. The shared module has important pathogenic, diagnostic and therapeutic implications.](https://figures.cochat.ai/paper-figures/f731883e01134f7e841fa09c1dee9931/modules-networks-and-systems-medicine-for-understanding-disease-and-aiding-figure-5.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Complex diseases such as cancer need to be studied on a systems level, because the interplay of highly diverse modalities (DNA mutations, Gene expression, Methylation, etc.) substantially contributes to disease progression [86].”
From Towards multi-modal causability with graph neural networks enabling information fusion for explainable ai (2021) · cites this paper as [86]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Emergence of Scaling in Random Networks
Barabási, A.-L., & Albert, R. (1999) · Science · doi:10.1126/science.286.5439.509 · Cited by 36,135
Self-citationLethality and centrality in protein networks
Jeong, H., Mason, S. P., Barabási, A.-L., & Oltvai, Z. N. (2001) · Nature · doi:10.1038/35075138 · Cited by 5,287 · cited 1×
“studied network design principles in model organisms like yeast cells or worms [15].”
BackgroundSelf-citationNetwork medicine: a network-based approach to human disease
Barabási, A.-L., Gulbahce, N., & Loscalzo, J. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2918 · Cited by 5,034 · cited 2×
“Systems medicine is an emerging discipline that aims to address the problem that a disease is rarely caused by malfunction of one individual gene product, but instead depends on multiple gene products that interact in a complex network [7].”
BackgroundSelf-citationmRNA-Seq whole-transcriptome analysis of a single cell
Tang, F., Barbacioru, C., Wang, Y., Nordman, E., Lee, C., Xu, N., Wang, X., Bodeau, J., Tuch, B. B., Siddiqui, A., et al. (2009) · Nature Methods · doi:10.1038/nmeth.1315 · Cited by 3,969 · cited 1×
“Recent developments in sequencing allow determination of single-cell genomes and transcriptomes [55,56], while mass cytometry enables the targeted quantification of proteins and their modifications in different cells from a heterogeneous population [57].”
BackgroundGoh, K.-I., Cusick, M. E., Valle, D., Childs, B., Vidal, M., & Barabási, A.-L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701361104 · Cited by 3,242
Self-citationTumour evolution inferred by single-cell sequencing
Navin, N., Kendall, J., Troge, J., Andrews, P., Rodgers, L., McIndoo, J., Cook, K., Stepansky, A., Levy, D., Esposito, D., et al. (2011) · Nature · doi:10.1038/nature09807 · Cited by 2,598 · cited 1×
“Recent developments in sequencing allow determination of single-cell genomes and transcriptomes [55,56], while mass cytometry enables the targeted quantification of proteins and their modifications in different cells from a heterogeneous population [57].”
BackgroundGenetics of rheumatoid arthritis contributes to biology and drug discovery
the RACI consortium, Okada, Y., the GARNET consortium, Wu, D., Trynka, G., Raj, T., Terao, C., Ikari, K., Kochi, Y., Ohmura, K., et al. (2014) · Nature · doi:10.1038/nature12873 · Cited by 2,310
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Rifai, N., Gillette, M. A., & Carr, S. A. (2006) · Nature Biotechnology · doi:10.1038/nbt1235 · Cited by 1,867 · cited 1×
“However, recent technological advances indicate that targeted proteomics may partly address these limitations and render the analysis of predetermined sets of proteins over large numbers of samples [58,59].”
BackgroundYıldırım, M. A., Goh, K.-I., Cusick, M. E., Barabási, A.-L., & Vidal, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1338 · Cited by 1,708 · cited 1×
“Indeed, genes targeted by drugs have more interactions than other genes [30], which increases the risk that a drug targeting a specific disease gene may have an off-target effect [31].”
BackgroundSelf-citationMining electronic health records: towards better research applications and clinical care
Jensen, P. B., Jensen, L. J., & Brunak, S. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3208 · Cited by 1,680 · cited 1×
“Other approaches to disease reclassification have involved mining of electronic health records to search for comorbidity patterns and underlying genetic variants [46-51].”
BackgroundSelf-citation
Research works printed but not linked: 1
- McShane LM, Cavenagh MM, Lively TG, Eberhard DA, Bigbee WL, Williams PM, Mesirov JP, Polley MYC, Kim KY, Tricoli JV, Taylor JM, Shuman DJ, Simon RM, Doroshow JH, Conley BA: Criteria for the use of omics-based predictors in clinical trials. Nature. 2013, 502: 317-320. · DOI · Paper page
Cited by
The role of inflammation and genetics in periodontal disease
Loos, B. G., & Van Dyke, T. E. (2020) · Periodontology 2000 · doi:10.1111/prd.12297 · Cited by 612
Mostafavi, S., Gaiteri, C., Sullivan, S. E., White, C. C., Tasaki, S., Xu, J., Taga, M., Klein, H.-U., Patrick, E., Komashko, V., et al. (2018) · Nature Neuroscience · doi:10.1038/s41593-018-0154-9 · Cited by 509
“A network-based perspective provides a more nuanced molecular definition of complex disease than do traditional single-gene associations because it provides a natural framework with which to assemble disparate single gene findings into disease mechanisms 5–8 .”
Holzinger, A., Malle, B., Saranti, A., & Pfeifer, B. (2021) · Information Fusion · doi:10.1016/j.inffus.2021.01.008 · Cited by 352
Integrated gut/liver microphysiological systems elucidates inflammatory inter‐tissue crosstalk
Chen, W. L. K., Edington, C., Suter, E., Yu, J., Velazquez, J. J., Velazquez, J. G., Shockley, M., Large, E. M., Venkataramanan, R., Hughes, D. J., et al. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26370 · Cited by 172
“This work is motivated by recent advances in systems biology, where cell-cell communication within and across multiple organs is conceptualized in the form of networks and modeled accordingly to address pathophysiology effectively (Gustafsson et al., 2014).”
BackgroundProblems, challenges and promises: perspectives on precision medicine
Duffy, D. J. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbv060 · Cited by 149
Metadata
- Authors
- Gustafsson, M., Nestor, C. E., Zhang, H., Barabási, A.-L., Baranzini, S., Brunak, S., Chung, K. F., Federoff, H. J., Gavin, A.-C., Meehan, R. R., Picotti, P., Pujana, M. Á., Rajewsky, N., Smith, K. G., Sterk, P. J., Villoslada, P., & Benson, M.
- Affiliations
- Linköping University (SE)
- University of California, San Francisco (US)
- Imperial College London (GB)
- Georgetown University Medical Center (US)
- European Molecular Biology Laboratory (DE)
- Institute of Genetics and Cancer (GB)
- University of Zurich (CH)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Max Delbrück Center (DE)
- University of Cambridge (GB)
- Amsterdam UMC Location University of Amsterdam (NL)
- Hospital Clínic de Barcelona (ES)
- Corresponding author
- Benson, Mikael
- ORCID
- Venue
- Genome Medicine
- Published
- 2014-10-17
- Volume
- 6
- Issue
- 10
- Pages
- 82-82
- ISSN
- 1756-994X (ISSN-L)
- PMC
- PMC4254417
- OpenAlex
- W2156695919
- Cited by
- 194
- References
- 70
- Citations by year
- 2026: 10 · 2025: 6 · 2024: 10 · 2023: 13 · 2022: 11 · 2021: 19 · 2020: 20 · 2019: 20 · 2018: 24 · 2017: 23 · 2016: 20 · 2015: 16 · 2014: 2
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Genome Medicine (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion, cc-by)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, public-domain)
- National University of Singapore (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- DiVA (Linkoping University) (submittedVersion, other-oa)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, cc-by)
- eScholarship (California Digital Library) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Technical University of Denmark, DTU Orbit (Technical University of Denmark, DTU) (submittedVersion, cc-by)
- Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
- Repository for Publications and Research Data (ETH Zurich) (submittedVersion, cc-by)
- ETH Zürich Research Collection (cc-by)
- Funders
- Wellcome Trust (100140)
- European Commission
- Linköpings Universitet
- Medical Research Council
- Biotechnology and Biological Sciences Research Council (BB/J021032/1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Health Sciences › Medicine › Health Informatics › Biomedical Text Mining and Ontologies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene Regulatory Network Analysis
- Keywords
- systems medicine, gene interaction networks, disease modules, multi-omics integration, network analysis, asthma, allergy, diabetes mellitus, obesity, candidate gene identification, diagnostic biomarkers, drug target prioritization, clinical implementation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modules, networks and systems medicine for understanding disease and aiding diagnosis. https://app.cochat.ai/papers/10.1186/s13073-014-0082-6
- The paper
- Gustafsson, M., Nestor, C. E., Zhang, H., Barabási, A.-L., Baranzini, S., Brunak, S., Chung, K. F., Federoff, H. J., Gavin, A.-C., Meehan, R. R., Picotti, P., Pujana, M. Á., Rajewsky, N., Smith, K. G., Sterk, P. J., Villoslada, P., & Benson, M. (2014). Modules, networks and systems medicine for understanding disease and aiding diagnosis. Genome Medicine. https://doi.org/10.1186/s13073-014-0082-6
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.